- New
-
Topics
- All Categories
- Metaphysics and Epistemology
- Value Theory
- Science, Logic, and Mathematics
- Science, Logic, and Mathematics
- Logic and Philosophy of Logic
- Philosophy of Biology
- Philosophy of Cognitive Science
- Philosophy of Computing and Information
- Philosophy of Mathematics
- Philosophy of Physical Science
- Philosophy of Social Science
- Philosophy of Probability
- General Philosophy of Science
- Philosophy of Science, Misc
- History of Western Philosophy
- Philosophical Traditions
- Philosophy, Misc
- Other Academic Areas
- Journals
- Submit material
- More
Medical research, risk, and bystanders
IRB: Ethics & Human Research 27 (4):1 (2005)
Abstract
This article has no associated abstract. (fix it)My notes
Similar books and articles
Missing the Forest: Further Thoughts on the Ethics of Bystander Risk in Medical Research.Jonathan Kimmelman - 2007 - Cambridge Quarterly of Healthcare Ethics 16 (4):483.
Making Risk-Benefit Assessments of Medical Research Protocols.Alex Rajczi - 2004 - Journal of Law, Medicine and Ethics 32 (2):338-348.
Medical risk and the right to an informed consent in clinical care and clinical research.Dennis John Mazur - 1998 - Tampa, Fla.: American College of Physician Executives.
Valuing risk: The ethical review of clinical trial safety.Jonathan Kimmelman - 2004 - Kennedy Institute of Ethics Journal 14 (4):369-393.
The Low Risk Research Ethics Application Process at CQUniversity Australia.Teresa Moore & Kristy Richardson - 2013 - Journal of Academic Ethics 11 (3):211-230.
Moral Bystanders and the Virtue of Forgiveness.Linda Radzik - 2010 - In Christopher R. Allers & Marieke Smit (eds.), Forgiveness in Perspective. Rodopi. pp. 66--69.
Retractions in the medical literature: how many patients are put at risk by flawed research?R. G. Steen - 2011 - Journal of Medical Ethics 37 (11):688-692.
Risk, cost-effectiveness and profit: Problems in cardiovascular research and practice.Thomas Kenner, Christa Einspieler & Andrea Holzer - 1986 - Theoretical Medicine and Bioethics 7 (3).
Beyond Human Subjects: Risk, Ethics, and Clinical Development of Nanomedicines.Jonathan Kimmelman - 2012 - Journal of Law, Medicine and Ethics 40 (4):841-847.
Legal, regulatory and ethical dimensions of mandatory clinical trial registration.Ron A. Bouchard - manuscript
Concepts of Risk in Nanomedicine Research.Linda F. Hogle - 2012 - Journal of Law, Medicine and Ethics 40 (4):809-822.
Clarifying confusions about coercion.Jennifer Susan Hawkins & Ezekiel J. Emanuel - 2005 - Hastings Center Report 35 (5):16-19.
Analytics
Added to PP
2013-10-30
Downloads
18 (#814,090)
6 months
4 (#800,606)
2013-10-30
Downloads
18 (#814,090)
6 months
4 (#800,606)
Historical graph of downloads
Citations of this work
Four Faces of Fair Subject Selection.Katherine Witte Saylor & Douglas MacKay - 2020 - American Journal of Bioethics 20 (2):5-19.
A framework for risk-benefit evaluations in biomedical research.Annette Rid & David Wendler - 2011 - Kennedy Institute of Ethics Journal 21 (2):141-179.
COVID-19 controlled human infection studies: worries about local community impact and demands for local engagement.Kyungdo Lee & Nir Eyal - 2021 - Journal of Medical Ethics 47 (8):539-542.
Human infection challenge studies in endemic settings and/or low-income and middle-income countries: key points of ethical consensus and controversy.Euzebiusz Jamrozik & Michael J. Selgelid - 2020 - Journal of Medical Ethics 46 (9):601-609.
Conceptualising Ethical Issues in the Conduct of Research: Results from a Critical and Systematic Literature Review.Élie Beauchemin, Louis Pierre Côté, Marie-Josée Drolet & Bryn Williams-Jones - 2022 - Journal of Academic Ethics 20 (3):335-358.
PhilPapers logo by Andrea Andrews and Meghan Driscoll.
This site uses cookies and Google Analytics (see our terms & conditions for details regarding the privacy implications). Use of this site is subject to terms & conditions.
All rights reserved by The PhilPapers Foundation
Server: philpapers-web-7c76586df8-5tf24 uwo